We value your privacy
This site uses cookies to improve your browsing experience, analyze site traffic, and show personalized content.
| No holders yet. | ||||||||||
Developed by BrioHealth, the new ventricular assist device (VAD) aims to improve biocompatibility and reduce risks like strokes and blood clots. "This device could rival transplant outcomes," said Dr. Mani Daneshmand, Emory's Director of Heart and Lung Transplant. Early trials suggest it could allow patients to live comfortably for decades. Source: Fox